The 2023 MIPS reporting deadline is April 1, 2024. 

Purchase your MIPSpro license by Feb. 29 for access to Customer Support during submission season.

Act fast – time is running out!

56
Days
:
 
09
Hours
:
 
11
Minutes
:
 
15
Seconds

You missed out!

Measure ID

Measure Title

Measure Details

PPRNET32



Screening for albuminuria in patients at risk for CKD (DM and/or HTN)



QCDR Name: Diabetes QCDR

Description: Test for albuminuria or urine protein in adults with Diabetes Mellitus or Hypertension and without CKD

Numerator: Test for albuminuria or urine protein (spot albumin to creatinine, albumin specific dipstick, urine protein/creat ration, 24 hr urine albumin, "microalbumin") in past 12 months

Denominator: Adults with active diagnoses of Diabetes Mellitus or Hypertension

Denominator Exceptions: N/A

 Denominator Exclusion: Patients meeting the criteria for CKD

HM1

ACE/ARB use

QCDR Name: Diabetes QCDR

Description: Percentage of T2D patients age 18-75 with elevated urinary protein excretions and/or reduced eGFR for whom an ACE or ARB has been prescribed

Numerator: Patients prescribed an ACE or ARB

Denominator: Patients 18-75 years of age by the end of the measurement year who had a diagnosis of type 2 diabetes with elevated urinary protein excretions and/or reduced eGFR during the measurement year or the year prior to the measurement year

Denominator Exceptions: N/A

Denominator Exclusions: Exclude patients who use hospice services or elect to use a hospice benefit any time during the measurement year, regardless of when the services began.
Exclude patients who did not have a diagnosis of diabetes , in any setting, during the measurement year or the year prior to the measurement year.

HM2

A1C treatment

QCDR Name: Diabetes QCDR

Description: Percentage of T2D patients 18-75 years of age with A1C ≥8.0% not at A1C goal who are treated with metformin

Numerator: Patients prescribed metformin

Denominator: Patients 18-75 years of age by the end of the measurement year who had a diagnosis of type 2 diabetes during the measurement year or the year prior to the measurement year

Denominator Exceptions: N/A

Denominator Exclusions: Exclude patients who use hospice services or elect to use a hospice benefit any time during the measurement year, regardless of when the services began.
Exclude patients who did not have a diagnosis of diabetes, in any setting, during the measurement year or the year prior to the measurement year and who had a diagnosis of gestational diabetes or steroid-induced diabetes in any setting, during the measurement year or the year prior to the measurement year. Exclude patients where metformin is contraindicated or not tolerated.

HM3

A1C in good control

QCDR Name: Diabetes QCDR

Description: Percentage of T2D patients 18-75 years of age by the end of the measurement period who had most recent hemoglobin less than 8.0%

Numerator: Patients whose most recent HbA1c level is less than 8.0% during the measurement year

Denominator: Patients 18-75 years of age by the end of the measurement year who had a diagnosis of type 2 diabetes during the measurement year or the year prior to the measurement year

Denominator Exceptions: N/A

Denominator Exclusions: Exclude patients who did not have a diagnosis of diabetes, in any setting, during the measurement year or the year prior to the measurement year and who had a diagnosis of gestational diabetes or steroid-induced diabetes in any setting, during the measurement year or the year prior to the measurement year